可孚医疗：9月19日召开董事会会议

Group 1 - The core point of the article is that Kefu Medical announced the adjustment of its restricted stock incentive plan during a board meeting held on September 19, 2025, and provided details on its revenue composition for the first half of 2025 [1] - Kefu Medical's market capitalization is reported to be 8.1 billion yuan [2] - In the first half of 2025, Kefu Medical's revenue composition shows that medical health products accounted for 96.79% of total revenue, while other businesses contributed 3.21% [1]